IP Verse

Teva Pharmaceuticals patent opposition analysis

The comprehensive analysis of Teva Pharmaceuticals opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Teva Pharmaceuticals

Stay updated with the latest patent oppositions filed by Teva Pharmaceuticals

Patent NumberTitleApplicantOpposition DateOpposition Company
EP2120568
Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative DisordersCELATOR PHARMACEUTICALSAug 15, 2018TEVA PHARMACEUTICAL INDUSTRIES LTD
EP2959877
Closed Fluid Transfer SystemJ&J SOLUTIONSDec 1, 2017TEVA MEDICAL LTD.
EP2959879
Closed Fluid Transfer SystemJ&J SOLUTIONSDec 1, 2017TEVA MEDICAL LTD.
EP2906218
Beta-2-Adrenoceptor Agonist For The Treatment Of CoughBOEHRINGER INGELHEIMSep 13, 2017TEVA PHARMACEUTICALS
EP2641628
Two-Chambered Container-Cum-Syringe And Syringe-Filled AripiprazoleARTEApr 28, 2016NORTON HEALTHCARE

Top clients of Teva Pharmaceuticals

Top companies who are the clients of Teva Pharmaceuticals

CompanyTotal
TEVA MEDICAL LTD.4
TEVA PHARMACEUTICAL INDUSTRIES LTD2
NORTON HEALTHCARE1
TEVA PHARMACEUTICALS1